JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Short Interest Update

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 100 shares, a decrease of 50.0% from the January 15th total of 200 shares. Based on an average daily volume of 500 shares, the days-to-cover ratio is currently 0.2 days.

Hedge Funds Weigh In On JPMorgan Healthcare Leaders ETF

An institutional investor recently bought a new position in JPMorgan Healthcare Leaders ETF stock. Krilogy Financial LLC purchased a new stake in shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 10,212 shares of the company’s stock, valued at approximately $517,000. Krilogy Financial LLC owned approximately 6.81% of JPMorgan Healthcare Leaders ETF at the end of the most recent reporting period.

JPMorgan Healthcare Leaders ETF Price Performance

Shares of NASDAQ:JDOC opened at $53.83 on Friday. The company has a market cap of $8.07 million, a P/E ratio of 27.37 and a beta of 0.61. The stock’s fifty day moving average price is $52.97 and its 200-day moving average price is $57.46. JPMorgan Healthcare Leaders ETF has a 1 year low of $50.54 and a 1 year high of $63.49.

JPMorgan Healthcare Leaders ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 27th. Shareholders of record on Tuesday, December 24th were issued a dividend of $0.3276 per share. The ex-dividend date of this dividend was Tuesday, December 24th.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.